Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Top-5 Trends in Virtual KOL Engagement

    February 12, 2024 | Conference engagement, Delphi method, Digital Content Council, Online community boards, Patient journey mapping, Trends in virtual collaboration, webinar 

    Register now for one of our upcoming webinars (February 26-28)

    We’re taking a look at the top trends from 2023 and share our predictions for the new year.

    Our expert speakers will share their unique industry insights and the “best of the best” virtual collaboration and insight-gathering programs from 2023. They will tie in these trends with tips and best practices for how to optimize your insight-gathering programs, conference engagements, patient-centricity efforts, and HCP- or patient-facing materials.

    Register now to learn more about:

    • The most sought-after and innovative digital programs of 2023/24
    • Novel (and more efficient) ways to engage KOLs at conferences
    • Online patient journey mapping for understanding the patient experience and discovering healthcare gaps
    • Asynchronous Delphi reviews for co-creation of consensus papers, guidelines, and other resources
    • Digital Content Councils
    • Benefits of leveraging an all-in-one, proprietary virtual platform for all of the above programs
    • Plus much more!

    This content was provided by Impetus Digital

    Company Details

    - PMLiVE

    Impetus Digital

    Email
    Website

     Latest Content from  Impetus Digital 

    Top-5 Trends in Virtual KOL Engagement

    Register now for one of our upcoming webinars (February 26-28)

    Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

    In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

    Patient Advocate Engagement: A Customer Story

    Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

    Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

    In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

    Trends in Virtual Collaboration

    Join us for a look at the top-5 emerging virtual collaboration trends...

    Advisor Questions on Potential Data or Knowledge Gaps

    As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

    On a journey to diverse, inclusive, and more efficient rare disease trials

    Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...

    Versatility! Top 10 benefits of virtual advisory boards

    Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform...

    Clinical Trials Investigator and Patient Engagement Planning: A Customer Story

    In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning Longitudinal Expert Engagement Plan™ (LEEP™) to conduct an informal...

    New Playbook Alert: Virtual Patient Engagement

    Authentic patient engagement and insight-gathering are becoming must-haves in Pharma. However, multiple obstacles remain before patient-centricity becomes more than a buzzword. In our latest playbook, we take a deep dive...